Abstract
Diffuse low-grade gliomas (LGGs) form a heterogeneous subgroup of gliomas in adults. Chromosome (chr) arms 1p/19q codeletion and IDH mutation have been shown to be closely associated with oligodendroglial phenotype and better prognosis. We sought to identify relevant biomarkers in non 1p/19q codeleted LGGs. We characterized a retrospective series of 126 LGGs using genomic arrays, microsatellite analysis, IDH sequencing, MGMT promoter methylation assay, and p53 expression analysis. Our study confirms that 1p/19q codeletion, mutually exclusive with p53 overexpression, was associated with: (i) better prognosis, (ii) oligodendroglial phenotype, (iii) MGMT promoter methylation, and (iv) IDH mutation. Interestingly, 1p/19q codeleted tumors occur in older patients at diagnosis. Our study shows that non 1p/19q codeleted LGGs can be divided in 5 main genomic subgroups: (i) 11p loss, (ii) 19q loss (iii) 7 gain, (iv) 19 gain, and (v) unclassified. In non 1p/19q codeleted LGGs, we demonstrated that (i) 11p loss is associated with astrocytoma phenotype and has an independent negative prognostic value, and (ii) 19q loss diminished the favorable prognostic value of IDH mutation. Our findings were validated in an independent cohort of 98 LGGs....Continue Reading
References
Apr 1, 1997·Cancer·S W CoonsD K Pearl
Feb 2, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J S SmithR B Jenkins
Feb 25, 2003·Cancer·Martin J van den BentJohan M Kros
May 15, 2003·Brain Pathology·Chiaki KomineTakao Fukushima
Jul 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K Hoang-XuanJ Y Delattre
Aug 27, 2004·Cancer·Marko StänderFriedrich W Kreth
Sep 24, 2004·Bioinformatics·Philippe HupéEmmanuel Barillot
Jun 28, 2005·Journal of Neuropathology and Experimental Neurology·Hiroko Ohgaki, Paul Kleihues
May 24, 2006·BMC Bioinformatics·Pierre NeuvialEmmanuel Barillot
Aug 11, 2006·Genome Research·Sharon J DiskinGregory R Grant
Oct 19, 2006·Cancer Research·Robert B JenkinsJan C Buckner
Dec 29, 2006·Annals of Neurology·Sibille EverhardJoëlle Thillet
Dec 14, 2007·International Journal of Cancer. Journal International Du Cancer·Ahmed IdbaihOlivier Delattre
Feb 21, 2009·The New England Journal of Medicine·Hai YanDarell D Bigner
Jun 26, 2009·Acta Neuropathologica·Christian HartmannAndreas von Deimling
Apr 30, 2010·Neurology·M LabussièreM Sanson
Oct 27, 2010·Neurology·C HouillierJ-Y Delattre
Nov 4, 2010·Nature Reviews. Neurology·T David Bourne, David Schiff
Nov 16, 2010·The American Journal of Pathology·Young-Ho KimHiroko Ohgaki
Nov 17, 2010·Acta Neuropathologica·Philippe MetellusDominique Figarella-Branger
Mar 18, 2011·Genes, Chromosomes & Cancer·Hanne-Sofie S DahlbackSverre Heim
May 12, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Christian HartmannUNKNOWN German Glioma Network
Aug 6, 2011·Molecular Cancer Research : MCR·Adriana BorrielloFulvio Della Ragione
Aug 6, 2011·Science·Chetan BettegowdaKenneth W Kinzler
Sep 23, 2011·Journal of Translational Medicine·Sheng-Hua ChuPu-Cha Jiang
Feb 2, 2012·Cancer·Véronique QuillienDominique Figarella-Branger
Aug 8, 2012·Oncotarget·Yuchen JiaoHai Yan
Sep 19, 2012·Pharmacology & Therapeutics·H F van ThuijlJ C Reijneveld
Oct 30, 2012·Molecular Cell·Stephan SingerCarol Prives
Oct 30, 2012·Oncotarget·Kasthuri KannanJason T Huse
Mar 27, 2013·Proceedings of the National Academy of Sciences of the United States of America·Patrick J KillelaHai Yan